Total planned funding: $766,605,938
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $175,817,360 |
| Uganda | $120,235,034 |
| Kenya | $90,031,046 |
| Zambia | $85,116,901 |
| Mozambique | $74,561,763 |
| Côte d'Ivoire | $49,267,663 |
| Tanzania | $46,649,625 |
| Zimbabwe | $42,319,065 |
| Haiti | $17,644,125 |
| Rwanda | $14,838,082 |
| Vietnam | $14,443,925 |
| Eswatini | $7,599,895 |
| South Africa | $7,542,051 |
| Malawi | $6,754,489 |
| Democratic Republic of the Congo | $5,764,711 |
| Botswana | $4,756,138 |
| South Sudan | $1,214,992 |
| Burundi | $1,022,411 |
| Guyana | $881,501 |
| Cambodia | $50,217 |
| Dominican Republic | $48,986 |
| Ukraine | $25,824 |
| Ethiopia | $20,134 |
Organizational Types
| Private Contractor | $584,480,017 |
| Host Country Government Agency | $95,439,998 |
| NGO | $72,984,303 |
| Unknown | $10,786,863 |
| Own Agency | $2,061,106 |
| Other USG Agency | $569,897 |
| University | $147,054 |
| FBO | $136,700 |
| Implementing Agency | $0 |
Program Areas
| Treatment | $766,605,938 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $766,605,938 |
Top Partner Programs
Medical Access Uganda Limited:
$66,091,524
View countries